HQY at a glance
HEALTHEQUITY, INC. (HQY, SEC CIK 1428336) filed its latest 10-K annual report on March 17, 2026, a 10-Q quarterly report on August 27, 2026, an 8-K current report on September 30, 2026 and Form 4 insider filings as recently as September 18, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended January 31, 2026 (FY2026), HEALTHEQUITY, INC. (HQY) reported revenue of $1.3 billion (up 9.5% from FY2025) and net income of $215.2 million. Diluted EPS was $2.46.
- As of June 30, 2026, 37 institutional investment managers tracked by SignalX reported holding HEALTHEQUITY, INC. (HQY) shares worth $3.7 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by DILLON ADRIAN T on August 25, 2026 of 1,332 shares at $105.26 per share.
- In the last 90 days, HQY insiders reported 0 open-market purchases ($0) and 3 open-market sales ($1.0M) on Form 4, a net sale of $1.0M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2026
- $1.3B
- +9.5% vs prior year
- Insiders · 90 days
- 0 buys · 3 sells
- Net −$1.0M
- 13F holders
- 37 funds
- $3.7B · +2 vs prior quarter
- Latest 8-K
- Sep 30, 2026
- Item 5.02 · Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Jan 31, 2026
Business Overview
- Core business: Technology-enabled administration of tax-advantaged health savings accounts (HSAs) and complementary consumer-directed benefits (CDBs) for employers
- New acquisition: BenefitWallet HSA portfolio with 616,000 HSAs and $2.7 billion in assets acquired for $425 million in fiscal 2025
- Strategic focus: Increased AI integration for customer service, process efficiency, and platform modernization to enhance member experience and scalability
- Quantitative metric: Administered 10.6 million HSAs and 7.2 million complementary CDBs totaling 17.8 million accounts as of January 31, 2026
- Notable fact: Increased HSA market share to 20% by June 2025, largest by number of accounts and second largest by assets per Devenir report
Risk Factors
- Regulatory risk: Compliance with July 2025 "One Big Beautiful Bill Act" expanding HSA availability to Bronze and Catastrophic plans with uncertain impact on business
- Macroeconomic risk: Interest rate fluctuations affect custodial revenue; uses Treasury bond forwards to hedge but still exposed to prevailing government-driven rates
- Operational risk: Integration and efficient consolidation of acquired HSA portfolios critical for growth from competitors divesting non-core HSA businesses
- Competitive risk: Competition from Fidelity Investments, UnitedHealth Group's Optum, and Webster Bank with greater resources for product development and support
- Financial risk: Variable interest expense on Revolving Credit Facility due to changes in prevailing interest rates impacting cost structure
Management Discussion & Analysis
- Cash and cash equivalents $318.9M as of Jan 31, 2026, up from $295.9M as of Jan 31, 2025
- Liquidity sources include cash balances, custodial/service/interchange collections, Revolving Credit Facility availability
- Revolving Credit Facility up to $1.0B matures Aug 23, 2029, for working capital, acquisitions, and general corporate purposes
- No revenue, profitability, or segment performance data provided in the MD&A section
- No capital allocation figures for buybacks, dividends, or capex disclosed in the MD&A section
AI summary of the HQY 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jul 31, 2026
Management Discussion & Analysis
- HSAs 10.739M, up 8% YoY; CDBs 7.016M, down 2% YoY
- Total HSA Assets $37.921B, up 14% YoY; HSA investments $20.552B, up 28%
- Client-held funds $931M, up 14% YoY; average quarter-to-date balance $936M, up 6%
- Outlook: continued HSA growth opportunities alongside interest-rate, tax-policy, regulatory, and competitive risks
Risk Factors
- No material changes to 10-K risk factors for fiscal year ended January 31, 2026
- Carried-forward risks could materially adversely affect business, financial condition, and results
- Unidentified or currently immaterial risks could affect operations unexpectedly
- No newly triggered regulatory, legal, operational, competitive, or financial risk disclosed
AI summary of the HQY 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Noémie Heuland appointed director, expanding Board to 11 members from 10
- Moody’s CFO joins Audit and Risk Committee and Cybersecurity and Technology Committee
Item 7.01: Regulation FD Disclosure
- Press release announces Ms. Heuland’s appointment to HealthEquity’s Board
- Board addition may affect governance, oversight, and strategic decision-making
Item 2.02: Results of Operations and Financial Condition
- HealthEquity furnished an August 27, 2026 press release covering fiscal-year 2026 results
- Detailed financial results and management commentary are in Exhibit 99.1
Item 5.07: Submission of Matters to a Vote of Security Holders
- Stockholders approved all five proposals at the June 25, 2026 annual meeting
- All ten director nominees elected through the 2027 annual meeting
AI summaries of HQY 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for HQY
Don't miss the next HQY filing
- Alerts as it files. A push when HQY files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut HQY, by share count.
- Ask anything. An AI agent that reads every HQY filing and answers with sources.
HQY alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Neeleman Stephen | G | Sep 17, 2026 | 1,500 | - |
| DILLON ADRIAN T | Sell | Aug 25, 2026 | 1,332 | $105.26 |
| DILLON ADRIAN T | M | Aug 25, 2026 | 7,632 | - |
| DILLON ADRIAN T | Sell | Aug 25, 2026 | 6,300 | $104.47 |
| DILLON ADRIAN T | M | Aug 25, 2026 | 7,632 | $32.50 |
| Fiore Michael Henry | Sell | Jul 10, 2026 | 2,354 | $95.00 |
| Gathright Michael | F | Jul 9, 2026 | 2,270 | $93.07 |
| Lucania James M | F | Jul 8, 2026 | 2,839 | $95.08 |
Financial SummaryXBRL
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $1.2B | $1.3B |
| Gross Profit | - | $777.3M | $913.1M |
| Operating Income | - | $162.3M | $322.5M |
| Net Income | - | $96.7M | $215.2M |
| Gross Margin | - | 64.8% | 69.5% |
| Op. Margin | - | 13.5% | 24.6% |
| Net Margin | - | 8.1% | 16.4% |
| Balance Sheet | |||
| Total Assets | $3.2B | $3.4B | $3.4B |
| Equity | $2.0B | $2.1B | $2.1B |
| ROE | - | 4.6% | 10.2% |
| Per Share | |||
| EPS | - | $1.09 | $2.46 |
| Cash Flow | |||
| Operating CF | - | $339.9M | $457.1M |
| CapEx | - | $2.1M | $2.0M |
Source: XBRL data in HEALTHEQUITY, INC. (HQY)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate HQY share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 37 | $3.70B |
| Q1 2026 | 35 | $3.17B |
| Q4 2025 | 32 | $3.61B |
| Q3 2025 | 33 | $4.17B |
| Q2 2025 | 33 | $4.58B |
| Q1 2025 | 29 | $2.79B |
| Q4 2024 | 23 | $2.65B |
| Q3 2024 | 20 | $979.8M |
- Morgan Stanley+2.06M (+83%)
- BlackRock+745.5K (+7%)
- Citadel Advisors LLC+414.1K (+154%)
- FMR LLC (Fidelity)+403.5K (+36%)
- Bank of America Corp+284.7K (+33%)
- Millennium Management−558.9K (-69%)
- Ameriprise Financial−512.2K (-80%)
- Invesco Ltd−254.6K (-56%)
- Citigroup−191.6K (-76%)
- Vanguard Capital Management LLC−183.0K (-5%)
- D.E. Shaw & Co+20.4K
- Blackstone Group+6.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 242 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
HQY filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Sep 30, 2026 | - | Analysis | - |
| 4 | Sep 18, 2026 | - | - | - |
| 8-K | Aug 27, 2026 | - | Analysis | - |
| 4 | Aug 27, 2026 | - | - | - |
| 10-Q | Aug 27, 2026 | Jul 31, 2026 | Analysis | |
| 4 | Jul 14, 2026 | - | - | - |
| 4 | Jul 13, 2026 | - | - | - |
| 4 | Jul 10, 2026 | - | - | - |
| 4 | Jul 10, 2026 | - | - | - |
| 4 | Jul 10, 2026 | - | - | - |
| 4 | Jul 10, 2026 | - | - | - |
| 4 | Jul 10, 2026 | - | - | - |
| 4 | Jul 7, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 8-K | Jun 26, 2026 | - | Analysis | - |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 1, 2026 | - | - | |
| 4 | Jun 1, 2026 | - | - |
Related Information Technology companies
- ACN · AccentureServices-Business Services, NEC
- ACVA · ACV Auctions Inc.Services-Business Services, NEC
- ADV · Advantage Solutions Inc.Services-Business Services, NEC
- AKAM · Akamai TechnologiesServices-Business Services, NEC
- BABA · Alibaba Group Holding LtdServices-Business Services, NEC
- ALIT · Alight, Inc. / DelawareServices-Business Services, NEC
- CASS · CASS INFORMATION SYSTEMS INCServices-Business Services, NEC
- CBZ · CBIZ, Inc.Services-Business Services, NEC
HQY SEC filings: frequently asked questions
Are HQY insiders buying or selling?
In the last 90 days, HEALTHEQUITY, INC. (HQY) officers, directors and 10% owners reported no open-market purchases and 3 open-market sales worth $1.0 million by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold HQY stock?
As of June 30, 2026, the largest HEALTHEQUITY, INC. (HQY) holders among the 13F filers tracked by SignalX were BlackRock ($1.0 billion), Morgan Stanley ($410.7 million), Vanguard Portfolio Management LLC ($366.5 million), Vanguard Capital Management LLC ($328.8 million), State Street Corp ($292.7 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was HQY's revenue in fiscal year 2026?
For the fiscal year ended January 31, 2026 (FY2026), HEALTHEQUITY, INC. (HQY) reported revenue of $1.3 billion (up 9.5% from FY2025) and net income of $215.2 million. Diluted EPS was $2.46. The figures come from the XBRL data in the 10-K.
What are the main risks in HQY's latest 10-K?
In the 10-K filed March 17, 2026, HEALTHEQUITY, INC. (HQY) flagged: Regulatory risk: Compliance with July 2025 "One Big Beautiful Bill Act" expanding HSA availability to Bronze and Catastrophic plans with uncertain impact on business. Macroeconomic risk: Interest rate fluctuations affect custodial revenue; uses Treasury bond forwards to hedge but still exposed to prevailing government-driven rates. (AI summary of the Risk Factors section.)
What did HQY report in its latest 8-K?
HEALTHEQUITY, INC. (HQY) filed an 8-K on September 30, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers) and Item 7.01 (Regulation FD Disclosure). Noémie Heuland appointed director, expanding Board to 11 members from 10.
What are the latest HQY SEC filings?
HEALTHEQUITY, INC. (HQY) filed its latest 10-K annual report on March 17, 2026, a 10-Q quarterly report on August 27, 2026, an 8-K current report on September 30, 2026 and a Form 4 insider filing on September 18, 2026.
What is HQY's SEC CIK number?
HEALTHEQUITY, INC. (HQY)'s SEC Central Index Key (CIK) is 1428336. EDGAR lists every HQY filing under that number.
Ask anything about HQY
The research agent reads HQY's filings, financials, insider trades and 13F holders, then answers with sources.